Publications by authors named "Heidrun Mitzel-Rink"

Claim this Profile
I
Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma.
Franziska K Krebs, Emily R Trzeciak, Sophia Zimmer, Deniz Özistanbullu, Heidrun Mitzel-Rink

Cancer Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-Derived GARP Induces Peripheral Regulatory T Cells-Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis.
Niklas Zimmer, Franziska K Krebs, Sophia Zimmer, Heidrun Mitzel-Rink, Elena J Kumm

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Ugur Sahin, Petra Oehm, Evelyna Derhovanessian, Robert A Jabulowsky, Mathias Vormehr, Heidrun Mitzel-Rink

Nature· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors.
Alvaro Moreira, Carmen Loquai, Claudia Pföhler, Katharina C Kähler, Samuel Knauss, Heidrun Mitzel-Rink

Eur J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study.
Julia K Tietze, Andrea Forschner, Carmen Loquai, Heidrun Mitzel-Rink, Lisa Zimmer

Oncotarget· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis